
Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Description
Novartis Venture Fund is a venture capital firm focused on companies that develop novel therapeutics and platforms.
Investor Profile
Novartis Venture Fund has made 257 investments, with 8 in the past 12 months and 26% as lead.
Stage Focus
- Series A (34%)
- Series B (30%)
- Series C (14%)
- Series Unknown (8%)
- Series D (7%)
- Seed (3%)
- Series E (2%)
- Post Ipo Equity (2%)
- Private Equity (1%)
Country Focus
- United States (64%)
- Switzerland (12%)
- United Kingdom (8%)
- France (2%)
- The Netherlands (2%)
- Ireland (2%)
- Finland (2%)
- Germany (2%)
- Spain (2%)
- Iceland (1%)
Industry Focus
- Biotechnology
- Health Care
- Therapeutics
- Medical
- Pharmaceutical
- Biopharma
- Life Science
- Medical Device
- Health Diagnostics
- Genetics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.